Novel mutations associated with metachromatic leukodystrophy:: Phenotype and expression studies in nine Czech and Slovak patients

被引:12
作者
Berná, L
Gieselmann, V
Poupetová, H
Hrebícek, M
Elleder, M
Ledvinová, J
机构
[1] Charles Univ Prague, Inst Inherited Metab Disorders, Fac Med 1, Prague 12808 2, Czech Republic
[2] Univ Bonn, Inst Physiol Chem, D-5300 Bonn, Germany
关键词
arylsulphatase A; metachromatic leukodystrophy; mutation analysis; transient expression;
D O I
10.1002/ajmg.a.30118
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Metachromatic leukodystrophy (MLD) is an inherited demyelinating disorder caused by the deficiency of arylsulphatase A (ASA). This defect leads to an accumulation of galactosylceramide I-3-sulphates (sulphatides) in lysosomes of different tissues. We report on mutations found in a group of nine patients from the Czech and Slovak Republics (former Czechoslovakia). Their diagnosis was confirmed by determination of the activity of arylsulphatase A in leukocytes and by abnormal urinary excretion of sulphatides. All alleles of the patients were identified and eight different mutations were found. They include four novel missense mutations in one infantile (D29N), one juvenile (C294Y), and three adult (C156R, G293S) patients. Four mutations were previously described sequence alterations (459 + 1G > A, G309S, I1 79S, and P426L). Polymorphisms characteristic for the ASA pseudodeficiency allele were not found in the patients. Substitutions of D29N, C294Y, and G293S in arylsulphatase A caused a severe reduction of enzyme activity in transient expression studies. In contrast, the C156R substitution reduces arylsulphatase A only to 50% of wild type ASA activity. Since no other mutations were found in this patient, the contribution of this mutation to the development of disease remains unclear. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:277 / 281
页数:5
相关论文
共 35 条
[1]   VECTORS FOR EFFICIENT EXPRESSION IN MAMMALIAN FIBROBLASTOID, MYELOID AND LYMPHOID-CELLS VIA TRANSFECTION OR INFECTION [J].
ARTELT, P ;
MORELLE, C ;
AUSMEIER, M ;
FITZEK, M ;
HAUSER, H .
GENE, 1988, 68 (02) :213-219
[2]  
BALDINGER S, 1987, CLIN GENET, V31, P70
[3]   Determination of urinary sulfatides and other lipids by combination of reversed-phase and thin-layer chromatographies [J].
Berná, L ;
Asfaw, B ;
Conzelmann, E ;
Cerny, B ;
Ledvinová, J .
ANALYTICAL BIOCHEMISTRY, 1999, 269 (02) :304-311
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   SWEAT GLAND VACUOLES IN UNVERRICHT-LUNDBORG DISEASE - A CLUE TO DIAGNOSIS [J].
COCHIUS, J ;
CARPENTER, S ;
ANDERMANN, E ;
ROULEAU, G ;
NOUSIAINEN, U ;
KALVIAINEN, R ;
FARRELL, K ;
ANDERMANN, F .
NEUROLOGY, 1994, 44 (12) :2372-2375
[6]  
CoulterMackie M, 1997, AM J MED GENET, V73, P32, DOI 10.1002/(SICI)1096-8628(19971128)73:1<32::AID-AJMG7>3.0.CO
[7]  
2-R
[8]   Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene:: a cystic fibrosis mutation of Slavic origin common in Central and East Europe [J].
Dörk, T ;
Macek, M ;
Mekus, F ;
Tümmler, B ;
Tzountzouris, J ;
Casals, T ;
Krebsová, A ;
Koudová, M ;
Sakmaryová, I ;
Macek, M ;
Vávrová, V ;
Zemková, D ;
Ginter, E ;
Petrova, NV ;
Ivaschenko, T ;
Baranov, V ;
Witt, M ;
Pogorzelski, A ;
Bal, J ;
Zékanowsky, C ;
Wagner, K ;
Stuhrmann, M ;
Bauer, I ;
Seydewitz, HH ;
Neumann, T ;
Jakubiczka, S ;
Kraus, C ;
Thamm, B ;
Nechiporenko, M ;
Livshits, L ;
Mosse, N ;
Tsukerman, G ;
Kadási, L ;
Ravnik-Glavac, M ;
Glavac, D ;
Komel, R ;
Vouk, K ;
Kucinskas, V ;
Krumina, A ;
Teder, M ;
Kocheva, S ;
Efremov, GD ;
Onay, T ;
Kirdar, B ;
Malone, G ;
Schwarz, M ;
Zhou, ZQ ;
Friedman, KJ ;
Carles, S ;
Claustres, M .
HUMAN GENETICS, 2000, 106 (03) :259-268
[9]  
ELLEDER M, 1990, CS PATOL, V26, P250
[10]  
FLUHARTY AL, 1991, AM J HUM GENET, V49, P1340